Recombinant SARS-CoV Nucleocapsid [GST] (aa 1-49/192-220) (VAng-Wyb8618)
SARS-CoV Nucleocapsid (aa 1-49/192-220), recombinant protein from E. coli, 1 mg/mL.
Datasheet
Specifications
Source
E. coli
Target
Coronavirus
Type
Viral Antigens
Applications
ELISA and Western Blot.
Formulation
50 mM Tris-HCl, 60 mM Sodium Chloride containing 50% Glycerol.
Purity
> 95% pure by SDS-PAGE.
Storage
Store at -20°C.
Antigen Information
Introduction
The SARS coronavirus, sometimes shortened to SARS-CoV, is the virus that causes severe acute respiratory syndrome (SARS). On April 16, 2003, following the outbreak of SARS in Asia and secondary cases elsewhere in the world, the World Health Organization (WHO) issued a press release stating that the coronavirus identified by a number of laboratories was the official cause of SARS. Samples of the virus are being held in laboratories in New York, San Francisco, Manila, Hong Kong, and Toronto. protein E is a kinesin-like motor protein that accumulates in the G2 phase of the cell cycle. Unlike other centromere-associated proteins, it is not present during interphase and first appears at the centromere region of chromosomes during prometaphase. CENPE is proposed to be one of the motors responsible for mammalian chromosome movement and/or spindle elongation.
Alternative Names
SARS (Severe Acute Respiratory Syndrome) Virus; Nidovirales; Coronaviridae; Coronavirus; SARS coronavirus; SARS; Severe acute respiratory syn
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
